Related Experiment Videos
Sulphonylureas and insulin resistance
Summary
A diabetic patient developed severe insulin resistance due to gangrene, requiring high insulin doses. Amputation led to temporary remission, linked to antibody-bound insulin, but symptoms returned, resolved by chlorpropamide.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Immunology
Background:
- A case report details a diabetic patient with previously controlled blood glucose levels.
- The patient developed severe insulin resistance, necessitating 750-1000 units of insulin daily, coinciding with leg gangrene.
Observation:
- Following leg amputation, the patient experienced a 9-week remission from diabetes, requiring no insulin.
- This remission was attributed to a significant increase in circulating antibody-bound insulin.
Findings:
- Diabetic symptoms and insulin resistance recurred despite successful amputation site healing.
- Chlorpropamide therapy effectively eliminated the need for insulin, reducing daily requirements to zero.
- The reduction in insulin requirement with chlorpropamide was independent of changes in insulin antibody levels.
Implications:
- This case highlights the complex interplay between infection, insulin antibodies, and insulin resistance in diabetes management.
- It suggests that factors beyond insulin antibodies can influence insulin requirements and treatment efficacy.
- The findings underscore the potential role of alternative therapies like chlorpropamide in managing severe insulin resistance in specific diabetic contexts.